Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorMurgatroyd, Christopher
dc.contributor.authorPirrie, Lisa
dc.contributor.authorTran, Fanny
dc.contributor.authorSmith, Terry K.
dc.contributor.authorWestwood, Nicholas J.
dc.contributor.authorAdamson, Catherine S.
dc.date.accessioned2016-08-29T14:30:45Z
dc.date.available2016-08-29T14:30:45Z
dc.date.issued2016-09
dc.identifier.citationMurgatroyd , C , Pirrie , L , Tran , F , Smith , T K , Westwood , N J & Adamson , C S 2016 , ' Structure-activity relationships of the Human Immunodeficiency Virus type 1 maturation inhibitor PF-46396 ' , Journal of Virology , vol. 90 , no. 18 , pp. 8181-8197 . https://doi.org/10.1128/JVI.01075-16en
dc.identifier.issn0022-538X
dc.identifier.otherPURE: 243686503
dc.identifier.otherPURE UUID: c08634b2-71b0-470f-9a25-18dee3fc9b87
dc.identifier.otherWOS: 000382314100014
dc.identifier.otherScopus: 84984653332
dc.identifier.otherWOS: 000382314100014
dc.identifier.otherORCID: /0000-0003-0630-0138/work/56424159
dc.identifier.otherORCID: /0000-0001-7673-5212/work/60630451
dc.identifier.urihttp://hdl.handle.net/10023/9394
dc.descriptionThis work was funded by the University of St Andrews and Society for Applied Microbiology New Lecturer Research Grant awarded to CSA, Wellcome Trust grant (093228) awarded to TKS.en
dc.description.abstractHIV-1 maturation inhibitors are a novel class of antiretroviral compounds, which consist of two structurally distinct chemical classes; betulinic acid derivatives and the pyridone-based compound PF-46396. It is currently believed that both classes act by a similar mode of action to generate aberrant non-infectious particles via inhibition of CA-SP1 cleavage during Gag proteolytic processing. In this study we utilized a series of novel analogues, with decreasing similarity to PF-46396, to determine the chemical groups within PF-46396 that contribute to antiviral activity, Gag binding and the relationship between these essential properties. A spectrum of antiviral activity (active, intermediate, inactive) was observed across the analogue series with respect to CA-SP1 cleavage and HIV-1 (NL4-3) replication kinetics in Jurkat T cells. We demonstrate that selected inactive analogues are incorporated into WT immature particles and that one inactive analogue is capable of interfering with PF-46396 inhibition of CA-SP1 cleavage. Mutations that confer PF-46396 resistance can impose a defective phenotype on HIV-1 that can be rescued in a compound-dependent manner. Some inactive analogues retained the capacity to rescue PF-46396-dependent mutants (SP1-A3V, SP1-A3T, CA-P157S), implying that they can also interact with mutant Gag. The structure-activity relationships observed in this study demonstrate that (i) the tert-butyl group is essential for antiviral activity, but not an absolute requirement for Gag binding, (ii) the trifluromethyl group is optimal but not essential for antiviral activity and (iii) the 2-aminoindan group is important for antiviral activity and Gag binding but not essential as its replacement is tolerated.
dc.format.extent17
dc.language.isoeng
dc.relation.ispartofJournal of Virologyen
dc.rightsCopyright © 2016 Murgatroyd et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.en
dc.subjectQR355 Virologyen
dc.subjectBDCen
dc.subject.lccQR355en
dc.titleStructure-activity relationships of the Human Immunodeficiency Virus type 1 maturation inhibitor PF-46396en
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Biologyen
dc.contributor.institutionUniversity of St Andrews.School of Chemistryen
dc.contributor.institutionUniversity of St Andrews.Biomedical Sciences Research Complexen
dc.contributor.institutionUniversity of St Andrews.EaSTCHEMen
dc.identifier.doihttps://doi.org/10.1128/JVI.01075-16
dc.description.statusPeer revieweden
dc.date.embargoedUntil2016-08-26


This item appears in the following Collection(s)

Show simple item record